Halozyme provides disruptive drug delivery solutions with the goal of improving patient experiences and outcomes that can enhance the competitiveness of emerging and established therapies. To catch up on our latest news, updates and Industry Insights, please review the links below:
Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO® (Daratumumab And Hyaluronidase-fihj) As Treatment For Newly Diagnosed Patients With Light Chain (AL) Amyloidosis
/wp-content/uploads/logo_color.png00David Anderson/wp-content/uploads/logo_color.pngDavid Anderson2021-08-09 08:00:102021-08-13 12:57:54Inspire Week – Highlighting the Importance of Recharging the Mind, Body and Spirit
/wp-content/uploads/logo_color.png00David Anderson/wp-content/uploads/logo_color.pngDavid Anderson2021-01-28 08:00:132021-08-13 12:56:00You’re A Small Biotech — How Should You Implement A Pharmacovigilance System?
Insights Value Series: Introduction
/in Values Series /by ehennesWe want to provide some insight into our company’s values in an ongoing series on Halozyme’s Insights webpage. This series is an opportunity…
Inspire Week – Highlighting the Importance of Recharging the Mind, Body and Spirit
/in Company Updates /by David AndersonThank you to our patients, partners and shareholders for your continued support as we’ve learned to navigate through these unprecedented times…
You’re A Small Biotech — How Should You Implement A Pharmacovigilance System?
/in Executive Insights /by David AndersonWhen it comes to implementing strong pharmacovigilance practices at your company, there are a variety of components and capabilities…